ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 2761 - 2775 of 5448 products
Adlai Nortye In-Licenses Oncolytic's Cancer Drug in $86.6 Million Deal
$5.00
Available
Ascentage's IND Accepted in US for Inhibitor of Apoptosis Blocker
$5.00
Available
Shanghai Pharma Plans to Use M&A to Expand Overseas
$5.00
Available
Shanghai Pharma Acquires Cardinal's China Drug Distribution Business for $1.2 Billion
$5.00
Available
CorestoneBio Plans China JV with Boston's Respiratory Motion
$5.00
Available
Cygnus Raises $19.6 Million for Highly Accurate Sequencing Technology
$5.00
Available
RiboQuark Doses First Patient in China siRNA Trial
$5.00
Available
Arcus Completes $107 Million C Round with China VC Participation
$5.00
Available
Pfizer Sells 49% Stake in China Generic Drug JV
$5.00
Available
Valeant Sells Obagi to Fund that Includes China Regenerative Medicine
$5.00
Available
Ark Biosciences Partners with Calibr on Novel COPD Treatment
$5.00
Available
Genovis Finds Second China Distribution Partner for Enzyme Portfolio
$5.00
Available
US Denies Approval for Creat's $1.5 Billion Acquisition of Germany's Biotest
$5.00
Available
Cellular Biomedicine Opens Shanghai CAR-T Facility
$5.00
Available
Zhejiang Huahai In-licenses Immuno-Oncology Drug in $65 Million Deal
$5.00
Available